PTN News and Press, Palatin Technologies Inc. From 02/07/25

2025-02-07 08:11:24 ET Read the full article on Seeking Alpha For further details see: Palatin Technologies prices 4.69M shares in direct offering

Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement PR Newswire CRANBURY, N.J. , Feb. 7, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) ("Palatin" or the "Company"), a biopharmaceutical company dev...

Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide PR Newswire Last Patient / Last Visit Completed Topline Data Readout Expected Later This Quarter CRANBURY, N.J. , Feb. 6, 2025 /PRNewswire/ -- Palatin T...

Palatin Provides Update on Anticipated 2025 Corporate Milestones PR Newswire Obesity programs: Phase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Topline results expected 1Q calendar year 2025 ...